BridgeMD
New treatment option for Traumatic Brain Injury
Official title Effect of Graded Aerobic Exercise in Mild Traumatic Brain Injury
ClinicalTrials.gov ID: NCT06177509
What this study is testing
- What it's testing
- There is a paucity of knowledge about mechanisms behind mild traumatic brain injury (mTBI) subgroup's sustained problems, and effective interventions that can alleviate this disabling condition. Persistent Post-concussive Symptoms (PCS) affect between 20% and 30% of individuals after mTBI.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 60
You may be able to join if
- Diagnosis of mild TBI as defined by the World Health Organization (WHO)
- Diagnosis of PCS based on ICD-10 criteria for a minimum of 3 months to a maximum of 2 years
- Age 18-60 years.
- Reduced tolerance to physical activity/exercise intolerance (self-reported worsening of symptoms such as dizziness, nausea or headache during...
You likely can't join if
- Other neurological or severe psychiatric conditions listed in the medical record.
- Heart-lung disease.
- Extremity injuries that prevent physical exercise
- Drug addiction
- Insufficient understanding of the Norwegian language (unable to follow instructions and/or fill in forms).
- Normal BCTT.
The study team makes the final eligibility decision.
Where it's taking place
- Nesoddtangen, Norway
- Oslo, Norway
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nesoddtangen, Norway; Oslo, Norway. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.